Loading...

Molecular Partners AG

MLLCFPNK
Healthcare
Biotechnology
$4.22
$0.00(0.00%)

Molecular Partners AG (MLLCF) Stock Competitors & Peer Comparison

See (MLLCF) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
MLLCF$4.22+0.00%155.6M-1.98-$2.13N/A
NONOF$57.10+1.96%253.7B14.68$3.89+3.03%
CSLLY$70.42-2.37%136.3B22.78$3.09+1.88%
CMXHF$148.15-1.77%71.7B24.01$6.17+1.87%
UCBJF$235.70+0.74%45.3B29.89$7.98+0.66%
UCBJY$115.94+0.65%44B28.92$4.00+0.68%
ARGNF$619.44+0.00%37.9B31.54$19.64N/A
ODTC$22,005.00+29.44%24.1B1.07$20,580.00N/A
IVBXF$12.73+0.24%21.8B-1273.00-$0.01N/A
SBMFF$0.99+0.00%17.7B32.97$0.03+0.90%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

MLLCF vs NONOF Comparison August 2025

MLLCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, MLLCF stands at 155.6M. In comparison, NONOF has a market cap of 253.7B. Regarding current trading prices, MLLCF is priced at $4.22, while NONOF trades at $57.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

MLLCF currently has a P/E ratio of -1.98, whereas NONOF's P/E ratio is 14.68. In terms of profitability, MLLCF's ROE is -0.42%, compared to NONOF's ROE of +0.78%. Regarding short-term risk, MLLCF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for MLLCF.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;